Details for Patent: 7,229,613

Which drugs does patent 7,229,613 protect, and when does it expire?

Patent 7,229,613 protects WELCHOL and is included in three NDAs.

Protection for WELCHOL has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has sixty-four patent family members in eighteen countries.

Summary for Patent: 7,229,613

Title:	Method for lowering serum glucose
Abstract:	A method for treating hyperglycemia and/or reducing serum glucose levels in a patient that includes administering to the patient a therapeutically effective amount of an amine polymer is disclosed. In one embodiment, the amine polymer is aliphatic. Examples of polymers useful in an embodiment of the invention include sevelamer hydrogen chloride and colesevelam. The invention includes the use of amine polymers such as a cross-linked polymer characterized by a repeat unit having the formula: ##STR00001## and salts and copolymers thereof, where n is a positive integer and x is zero or an integer between 1 and about 4. Also described is a use, for the manufacture of a medicament, of a polymer that lowers serum glucose.
Inventor(s):	Burke; Steven K. (Sudbury, MA), Donovan; Joanne M. (Needham, MA)
Assignee:	Genzyme Corporation (Cambridge, MA)
Application Number:	10/125,700
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 7,229,613

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cosette	WELCHOL	colesevelam hydrochloride	BAR, CHEWABLE;ORAL	210895-001	Apr 3, 2019		DISCN	Yes	No						A METHOD FOR REDUCING SERUM GLUCOSE LEVELS IN ADULTS WITH TYPE 2 DIABETES MELLITUS
Cosette	WELCHOL	colesevelam hydrochloride	FOR SUSPENSION;ORAL	022362-001	Oct 2, 2009		DISCN	Yes	No					Y
Cosette	WELCHOL	colesevelam hydrochloride	FOR SUSPENSION;ORAL	022362-002	Oct 2, 2009	AB	RX	Yes	Yes					Y
Cosette	WELCHOL	colesevelam hydrochloride	TABLET;ORAL	021176-001	May 26, 2000	AB	RX	Yes	Yes					Y

International Family Members for US Patent 7,229,613

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	331525
Austria	380553
Austria	390927
Australia	2002252632
Australia	2002257145
Australia	2002257147
Brazil	0209020